5 Star Care: Optimizing the Approach to Neuromodulation Practice (NANS 2025)
Availability
On-Demand
Access expires 90 days after start
Cost
Active Member: $50.00
Non-Member: $75.00
Early Career Member: $50.00
Associate Member: $50.00
Trainee Member: $50.00
Industry Member: $50.00
Credit Offered
No Credit Offered

Recording Date: January 31, 2025

Expiration Date: January 30, 2028

This recorded session from the 2025 NANS Annual Meeting explores strategies for optimizing patient satisfaction and enhancing the overall neuromodulation patient experience. Expert faculty discuss key considerations in patient education, therapy selection, programming optimization, and practice management, with a focus on improving communication, setting appropriate expectations, and supporting long-term therapeutic success.

The session also examines how patient perceptions of neuromodulation are shaped through social media and real-world experiences, while highlighting approaches to building a successful neuromodulation practice centered on safety, outcomes, and patient satisfaction. In addition to faculty presentations, the activity features oral abstract presentations showcasing emerging research related to ECAP biomarkers, spinal cord stimulation programming, and upper limb pain outcomes. Through this activity, learners will gain practical insights into enhancing patient engagement, optimizing neuromodulation therapies, and developing clinical infrastructures that support positive patient outcomes.

To access the NANS eLearning Center and register for this content, log in using your NANS account username and password.

  • Have a NANS account? Click Login.
  • Need an account? Click Create Account and complete the form.
  • Questions about your NANS account? Email membership@nans.org or call (773) 648-7845 (Mon–Fri, 8:30 AM–5:00 PM CT).
Registration fees for this activity are nonrefundable. For additional details, please visit the NANS website to review the full refund policy.
Administrator, Advanced Practice Provider, Educator, Fellow, Medical student, Neurosurgeon, Neurologist, Nurse/Nurse Practitioner, Physician, Physician’s Assistant, Pain Medicine Physician, Physical Medicine and Rehab Physician, Researcher, Resident, Scientist, Trainee

Following participation in this activity, learners will be able to:

  • Anticipate questions and concerns patients may have regarding neuromodulation therapies, particularly the trial through implant process.
  • Improve strategies for programming and therapy selection to optimize therapeutic outcomes.
  • Construct an infrastructure to support patient education, safety, and long-term satisfaction with neuromodulation therapies.

Welcome    
David Provenzano, MD and Christine Hunt, DO

Social Media Documentation of Neuromodulation: What Can We Learn? Reported Patient Experiences with Neuromodulation on Social Media    
Christine Hunt, DO

Programming to Optimize Patient Outcomes: The Role of the MD and Patient    
David Provenzano, MD

Building a Successful Surgical Practice Focused on Clinical Outcomes, Safety and Patient Satisfaction    
Julie Pilitsis, MD, PhD

Oral Abstract Presentation: ECAP Study Premiere: Real-World IDE Study Showing Relationship between Physiologic ECAP Biomarkers and Pain Outcomes    
Jason Pope, MD

Oral Abstract Presentation: Cervical lead placement with DTM SCS programming for upper limb pain: Procura Study Outcomes
Thomas White, MD

Closing Discussion
David Provenzano, MD and Christine Hunt, DO

Any faculty member not on the disclosure list has reported nothing to disclose. 

David Provenzano, MD | Planner and Speaker
Avanos: Consulting Fees (Ongoing)|Avanos: Pain program has received research support. (Ongoing)|Boston Scientific: Consulting Fees (Ongoing)|Boston Scientific: Pain program has received research support. (Ongoing)|Medtronic: Consulting Fees (Ongoing)|Medtronic: Pain program has received research support. (Ongoing)|Nevro: Consulting Fees (Ongoing)|SI BONE: Consulting Fees (Ongoing)

Christine Hunt, DO | Planner and Speaker
Nevro: Funding for investigator-initiated research paid to my institution (Ongoing)

Julie Pilitsis, MD, PhD | Speaker
Abbott/St. Jude Medical: Consulting Fees (Ongoing)|Abbott/St. Jude Medical: Contracted Research (Ongoing)|Aim Medical Robotics: Future Stock Options (Ongoing)|Boston Scientific: Contracted Research (Ongoing)|Medtronic: Contracted Research (Ongoing)|NIH: Contracted Research (Ongoing)|Wavegate: Consulting Fees (Ongoing)

Jason Pope, MD | Oral Abstract Presenter
Abbott: Consulting Fees (Ongoing)|Abbott: Contracted Research (Ongoing)|Aurora Spine: Consulting Fees (Ongoing)|Aurora Spine: Contracted Research (Ongoing)|Aurora Spine: Own Stock (Ongoing)|Aurora Spine: Royalty (Ongoing)|Biotronik: Consulting Fees (Ongoing)|Biotronik: Contracted Research (Ongoing)|Celeri Health: Own Stock (Ongoing)|Mainstay: Consulting Fees (Ongoing)|Mainstay: Contracted Research (Ongoing)|Painteq: Consulting Fees (Ongoing)|Painteq: Contracted Research (Ongoing)|Painteq: Own Stock (Ongoing)|Saluda: Consulting Fees (Ongoing)|Saluda: Contracted Research (Ongoing)|Saluda: Stock Options (Ongoing)|Spark: Consulting Fees (Ongoing)|Spark: Own Stock (Ongoing)|SPR: Consulting Fees (Ongoing)|SPR: Contracted Research (Ongoing)|SPR: Stock Options (Ongoing)|Vertos: Consulting Fees (Ongoing)|Vertos: Contracted Research (Ongoing)|Vertos: Own Stock (Ongoing)|WISE: Consulting Fees (Ongoing)

Thomas White, MD | Oral Abstract Presenter
Medtronic: Consulting Fees (Ongoing)|Medtronic: Contracted Research (Ongoing)|Nevro: Consulting Fees (Ongoing)|Nevro: Contracted Research (Ongoing)|Vivex: Consulting Fees (Ongoing)

This is activity is not eligible for CME credit.
Powered By